139 related articles for article (PubMed ID: 31189610)
21. [Phosphoinositides: lipidic essential actors in the intracellular traffic].
Bertazzi DL; De Craene JO; Bär S; Sanjuan-Vazquez M; Raess MA; Friant S
Biol Aujourdhui; 2015; 209(1):97-109. PubMed ID: 26115715
[TBL] [Abstract][Full Text] [Related]
22. Unusual renal features of Lowe syndrome in a mildly affected boy.
Gropman A; Levin S; Yao L; Lin T; Suchy S; Sabnis S; Hadley D; Nussbaum R
Am J Med Genet; 2000 Dec; 95(5):461-6. PubMed ID: 11146467
[TBL] [Abstract][Full Text] [Related]
23. Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway.
Nakatsu F; Messa M; Nández R; Czapla H; Zou Y; Strittmatter SM; De Camilli P
J Cell Biol; 2015 Apr; 209(1):85-95. PubMed ID: 25869668
[TBL] [Abstract][Full Text] [Related]
24. Dual regulation of TRPV1 by phosphoinositides.
Lukacs V; Thyagarajan B; Varnai P; Balla A; Balla T; Rohacs T
J Neurosci; 2007 Jun; 27(26):7070-80. PubMed ID: 17596456
[TBL] [Abstract][Full Text] [Related]
25. RASSF4: Regulator of plasma membrane PI(4,5)P
Dickson EJ
J Cell Biol; 2017 Jul; 216(7):1879-1881. PubMed ID: 28634262
[TBL] [Abstract][Full Text] [Related]
26. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial.
Seminario MC; Wange RL
Immunol Rev; 2003 Apr; 192():80-97. PubMed ID: 12670397
[TBL] [Abstract][Full Text] [Related]
27. The inositol 5-phosphatase dOCRL controls PI(4,5)P2 homeostasis and is necessary for cytokinesis.
Ben El Kadhi K; Roubinet C; Solinet S; Emery G; Carréno S
Curr Biol; 2011 Jun; 21(12):1074-9. PubMed ID: 21658948
[TBL] [Abstract][Full Text] [Related]
28. The role of the Lowe syndrome protein OCRL in the endocytic pathway.
Sharma S; Skowronek A; Erdmann KS
Biol Chem; 2015 Dec; 396(12):1293-300. PubMed ID: 26351914
[TBL] [Abstract][Full Text] [Related]
29. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
Zhang X; Jefferson AB; Auethavekiat V; Majerus PW
Proc Natl Acad Sci U S A; 1995 May; 92(11):4853-6. PubMed ID: 7761412
[TBL] [Abstract][Full Text] [Related]
30. Rab5 regulates macropinocytosis by recruiting the inositol 5-phosphatases OCRL and Inpp5b that hydrolyse PtdIns(4,5)P2.
Maxson ME; Sarantis H; Volchuk A; Brumell JH; Grinstein S
J Cell Sci; 2021 Apr; 134(7):. PubMed ID: 33722976
[TBL] [Abstract][Full Text] [Related]
31. The inositol polyphosphate 5-phosphatases: traffic controllers, waistline watchers and tumour suppressors?
Astle MV; Horan KA; Ooms LM; Mitchell CA
Biochem Soc Symp; 2007; (74):161-81. PubMed ID: 17233589
[TBL] [Abstract][Full Text] [Related]
32. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
[TBL] [Abstract][Full Text] [Related]
33. A new Rab7 effector controls phosphoinositide conversion in endosome maturation.
Casanova JE; Winckler B
J Cell Biol; 2017 Oct; 216(10):2995-2997. PubMed ID: 28928133
[TBL] [Abstract][Full Text] [Related]
34. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate.
Rameh LE; Tolias KF; Duckworth BC; Cantley LC
Nature; 1997 Nov; 390(6656):192-6. PubMed ID: 9367159
[TBL] [Abstract][Full Text] [Related]
35. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
Ramos AR; Elong Edimo W; Erneux C
Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
[TBL] [Abstract][Full Text] [Related]
36. Kidney Tubular Ablation of
Inoue K; Balkin DM; Liu L; Nandez R; Wu Y; Tian X; Wang T; Nussbaum R; De Camilli P; Ishibe S
J Am Soc Nephrol; 2017 May; 28(5):1399-1407. PubMed ID: 27895154
[TBL] [Abstract][Full Text] [Related]
37. dOCRL maintains immune cell quiescence by regulating endosomal traffic.
Del Signore SJ; Biber SA; Lehmann KS; Heimler SR; Rosenfeld BH; Eskin TL; Sweeney ST; Rodal AA
PLoS Genet; 2017 Oct; 13(10):e1007052. PubMed ID: 29028801
[TBL] [Abstract][Full Text] [Related]
38. Mutations are not uniformly distributed throughout the OCRL1 gene in Lowe syndrome patients.
Lin T; Orrison BM; Suchy SF; Lewis RA; Nussbaum RL
Mol Genet Metab; 1998 May; 64(1):58-61. PubMed ID: 9682219
[TBL] [Abstract][Full Text] [Related]
39. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe].
Shi RM; Bian XH; Li LM; Liu XH
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831
[TBL] [Abstract][Full Text] [Related]
40. Lowe syndrome.
Loi M
Orphanet J Rare Dis; 2006 May; 1():16. PubMed ID: 16722554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
